Industrial Biotechnology Technology Offers

Vilnius University posted this:

Optical 3D Micro- and Nano-formation of Bioplastics The present technology allows printing complex 3D micro- and nano-structures from environmentally friendly plant-derived material – acrylated epoxidized soybean oil (AESO). Non-toxicity and high biodegradability enable application in biomedicine, micro-optics and nanophotonics.

Optical 3D Micro- and Nano-formation of Bioplastics

Covid-19 Innovation Challenges by Innoget posted this:

Viral RNA-dependent RNA Polymerases Viral RNA-dependent RNA Polymerases (RdRPs) Targeted Library (1259 compounds) with predicted activity against viral RdRPs is offered. It has been carefully designed using machine learning (artificial neural networks and Bayesian statistics

Viral RNA-dependent RNA Polymerases

Covid-19 Innovation Challenges by Innoget posted this:

SARS-CoV-2 RNA-dependent RNA Polymerase Targeted Library OtavaResearch Institute group presents SARS-CoV-2 RNA-dependent RNA Polymerase Targeted Library (1031 in-stock compounds with predicted activity against SARSCoV2 (RdRpp)).

SARS-CoV-2 RNA-dependent RNA Polymerase Targeted Library

Nadiia Kachaput posted this:
Project coordinator at Otava Research Institute

SARS-CoV-2 RNA-dependent RNA Polymerase Targeted Library OtavaResearch Institute group presents SARS-CoV-2 RNA-dependent RNA Polymerase Targeted Library (1031 in-stock compounds with predicted activity against SARSCoV2 (RdRpp)).

SARS-CoV-2 RNA-dependent RNA Polymerase Targeted Library

Covid-19 Innovation Challenges by Innoget posted this:

SARS-CoV-2 Papain-like ProteaseTargeted Library Using receptor based virtual screening OtavaResearchInstitute’s team designed the SARS-CoV-2 Papain-like Protease PLpro Targeted Library, which is contain 1058 stock compounds with predicted activity against this protease and ready for delivery.

SARS-CoV-2 Papain-like ProteaseTargeted Library

Leading Biology posted this:

Protein Expression and Purification Services Leading Biology strives to provide advanced platforms for protein expression and purification service. As a leading biotechnology service supplier, we offer a variety of protein expression and purification systems for high-level expression and sample purification.

Protein Expression and Purification Services

Covid-19 Innovation Challenges by Innoget posted this:

Systematic Computational Drug Repositioning to Treat COVID-19 Systematic Computational Drug Repositioning to Treat COVID-19 The genetic revolution which has taken place in recent years brings new opportunities to the field of drug discovery & repositioning. Using advanced comparative genomic, and data integration, our lab has been developing a state-of-the-art AI algorithm which maps drug and food supplements that are useful in treating diseases and improving health conditions. To create this algorithm, we have been integrating and analyzing massive amounts of genomic data from 1,600 genomes, 14 thousand compounds, 20,000 human genes, and a comprehensive database of phenotypic data. Project ID : 47-2020-10880

Systematic Computational Drug Repositioning to Treat COVID-19

Yissum - Research Development Company of the Hebrew University posted this:

Systematic Computational Drug Repositioning to Treat COVID-19 Systematic Computational Drug Repositioning to Treat COVID-19 Project ID : 47-2020-10880

Lidia Aguilera posted this:
Technology Transfer Officer at University of Luxembourg

RODENT PLATFORM - Luxembourg Centre for Systems Biomedicine The new University rodent facility is a shared resource of the Luxembourg Centre for Systems Biomedicine (LCSB) and the Life Science Research Unit (LSRU) and has been established to assist researchers in the development and analysis of various in vivo models including germ-free animals.

RODENT PLATFORM - Luxembourg Centre for Systems Biomedicine

Activatec - R&D posted this:
Manager at Activatec Ltd

Development and scale-up of technologies for the production of bio-based active compounds and ingredients • Scaling-up cutting-edge industrial ingredients manufacturing lines • Feasibility and Process designing and specifying unit operations and processes using low-value organic feedstocks • Specifying major items of process equipment and designing plant layouts considering process and regulatory requirements • Scheduling and managing project phases: detailed designs, installation, commissioning and validation • Managing effectively contractors and analysing proposals • Preparing safety and environmental reviews to define risks, hazards and safety strategy The products we target are biobased ingredients for nutraceuticals, cosmeceuticals, nutricosmetic: • Protein, Dietary Fiber, Stanols and Sterols, Prebiotics and Probiotics • Antioxidants, Botanicals compounds, Pectin, Collagen • Omega-3 fatty acids, Carotenes, and Flavonoids…

Rick Wadley posted this:
Innovation Manager at Vortex H20

PFAS-PFOA destruction via biological process We have developed bacteria and a carrier to treat PFAS and PFOA derivatives from the environment. This process can achieve 99% removal of the forever chemical. Removal from water streams and soil is achieved within this process. Combining our proven absorption method and the addition of our developed bacteria removes and locks the chemicals that do not allow it to release back into the environment or process. We are available for site removal and rehabilitation for large bodies of water and soil. We are able to halt the plume of contaminated ground water in site and remove the contaminant.

Arkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology

Synthesis of bioactive compounds We offer developed methods for the synthesis of known active substances by reaction in the presence of ultrasound and other eco-friendly methods. We also offer synthesis on request or a ready library of bioactive compounds with anti-cancer effect.

Synthesis of bioactive compounds

Arkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology

Bioactive haemostatic agents with advanced biological properties The technology comprises the obtainment of physically crosslinked aerogel with a unique chemical structure, which is responsible for the exceptional sorption capacity and antioxidant properties leading to scavenging of reactive radicals, especially oxygen (ROSS). Biomaterials are obtained from resources of fungal and plant origin. The use of biocompatible substances eliminates the use of toxic reagents, so the method of preparation is in line with the limitations of Green Chemistry.

Alex Michine posted this:
CEO at MetGen

METNIN™ TECHNOLOGY IS A LIGNIN REFINERY - SUSTAINABLE PATH TO REPLACE OLD BASED CHEMISTRY IN HIGH VALUE END USER PRODUCTS METNIN™ Technology is developed to refine lignin to end-user specific characteristics. Our technology is agnostic to lignin source and provides the missing link in the value-chain between crude lignin and high value lignin fractions for specific end user products. Metnin™ is enabling lignin valorisation towards wide range of drop-in sustainable solutions in e.g. coatings, resins, plasticizers, polyurethanes, and moisture/humidity resistance packaging. MetGen’s technology has been proven in multiple pre-commercial installations and enables cost-efficient conversion of lignin into cascade of intermediate building blocks of specific molecular size.Basic engineering package, CAPEX and OPEX estimate available.

METNIN™ TECHNOLOGY IS A LIGNIN REFINERY - SUSTAINABLE PATH TO REPLACE OLD BASED CHEMISTRY IN HIGH VALUE END USER PRODUCTS

Ivan Rodriguez Rosello posted this:
Licensing Manager at Universidad de Alicante

Novel bioadhesive for wound closure in animals or humans The Adhesion and Adhesives Laboratory research group has developed a new biomaterial for use as adhesive or tissue sealant applicable to both animals and humans. This invention solves the disadvantages of the adhesives known so far presenting optimal properties such as biocompatibility with living tissues, high adhesive capacity, adaptable to the tissue of the wound being bond, absence of toxicity and tissue regeneration properties. The group is looking for companies interested in acquiring this technology for commercial exploitation.

Novel bioadhesive for wound closure in animals or humans

1
2
3
4
5